What generic and biosimilar medicines are
Both are approved on evidence of equivalence, and the difference between them explains why the savings differ.
A generic contains the same active ingredient as the original in the same amount, and is approved on evidence that it performs equivalently in the body. The inactive ingredients can differ, which occasionally matters for an allergy or intolerance.
Biosimilars apply to medicines produced in living systems, which cannot be copied exactly. Approval is based on evidence of no clinically meaningful difference, and the savings are typically smaller than with conventional generics because production is harder.
Substitution rules are set by state law, and pharmacies may generally substitute an equivalent generic unless the prescriber indicates otherwise. Asking the prescriber whether substitution is appropriate is a reasonable question rather than a challenge.
Where no generic exists, there may still be a different medicine in the same class at a different price. That is a clinical judgement, which makes it a conversation with the prescriber rather than a decision to make at the counter.
Still have a question?
Describe what you are trying to work out and a member of the team will answer, or direct you to the office that makes the decision.